ARCH Venture Partners related stories
All articles and analysis
Women of Influence 2026: R-ZOur Women of Influence in Private Markets list celebrates the achievements of women in the alternative assets universe.
Side Letter: Apax valuations, North Carolina growth gains, KKR's new hiresNorth Carolina has been surprised on the upside by its VC and growth portfolio. Plus: Apax updates; KKR's new hires and why DFIs need to step up to the plate. Here's today's brief, for our valued subscribers only.
- Madison Dearborn in $1.6bn healthcare deal
New Mountain Capital and other shareholders are selling a majority stake in Ikaria.
- In this issue …
In this issue ? 2008-06-01 Staff Writer COMPANIES Alchemy Partners 6 Abraaj Capital 36 Actis 36,64 Advent International 8, 26 AIG 38 Alpha Associates 78&l
- Sapphire raises more than $50m for algae gas
The cleantech start-up’s second financing round, which includes an investment from Bill Gates’ wealth management firm, has pushed its total outside funding to more than $100m. Other investors include ARCH Venture, Venrock and the Wellcome Trust.
- British Columbia launches $90m venture fund of funds
The Canadian province has committed capital to six venture funds as it looks to spur economic development in the region.
- ARCH Venture Partners raises $400m
The US firm has raised $400 million for its seventh fund, to focus on early stage investments in biotechnology, advanced materials and specialty semiconductors.
- Wellcome Trust backs $52m venture funding
UK charity Wellcome Trust has made a rare direct investment in a $52 million seventh-round financing for Xtera Communications, a US optical networking and services company.
- Carlyle’s Grady appointed NVCA chairman
Robert Grady, a managing partner of Carlyle Venture Partners and former deputy assistant to George H. W. Bush, has been appointed NVCA chairman for 2006-2007.
- Deal round-up
Mowbray launches European venture FoF; Apatech raises £6.5 million in Series B financing; KKR leads $250m pharma round; ARCH Venture closes $350m Fund VI;